Oncol Lett |
Nov 9, 2015 | PubMed ID: 26870207 |
Read Article
Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study
Zhi-Liang Huang, Xun Cao, …, Zhesheng Wen
Article Snippet
“Briefly, formalin-fixed, paraffin-embedded specimens were sliced into 4 µm sections and baked for 1 h at 65°C.. The specimens were exposed to 10 mM citrate buffer (pH 6.0) for 10 min. Tumor sections were incubated for 60 min with the mouse monoclonal anti-human ERCC1 antibody (clone, 4F9; #UM500008; OriGene Technologies, Inc., Rockville, MD, USA; dilution, 1:150), rabbit polyclonal anti-BRCA1 antibody (#AR345-5R; BioGenex Laboratories, Inc., San Ramon, CA, USA; dilution, 1:50), rabbit monoclonal anti-RRM1 antibody (clone, EP242; #AC-0217RUO; Epitomics, Abcam, Cambridge, UK; dilution, 1:100) and mouse monoclonal anti-TUBB3 antibody (clone SDL3D10; #MU177-UC; BioGenex Laboratories, Inc.; dilution, 1:50).. The tissue sections were incubated with polyclonal goat anti-rabbit (#ab150077; Abcam; dilution, 1:200) and goat anti-mouse (#ab150115; Abcam; dilution, 1:200) IgG biotinylated secondary antibodies for.. “
Br J Cancer |
Oct 15, 2013 | PubMed ID: 24064970 |
Read Article
ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial
J E Bauman, M C Austin, …, R G Martins
Article Snippet
“ERCC1 evaluation Pre-cut slides sectioned at 4μ thickness were autostained using standard immunohistochemistry (IHC) protocols on Leica Bond III immunostainers (Leica Microsystems Inc, Buffalo Grove, IL, USA) according to the manufacturer’s operating instructions.. Three distinct ERCC1 antibodies were used, including an 8F1 monoclonal antibody (1 : 400 dilution, Neomarkers, Kalamazoo, MI, USA), a 4F9 monoclonal antibody (1 : 200 dilution, OriGene, Rockville, MD, USA), and an FL297 polyclonal antibody (1 : 50 dilution, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA).. Antigen retrieval was effected by heat-induced epitope retrieval (HIER) using Tris-EDTA for 20 min.”
DNA Repair Amst |
Feb 11, 2018 | PubMed ID: 29482102 |
Read Article
A novel antibody-based approach to detect the functional ERCC1-202 isoform.
Mei-Shiue Kuo, Julien Adam, …, Ken A Olaussen
“Abstract: ERCC1/XPF endonuclease plays an important role in multiple DNA repair pathways and stands as a potential prognostic and predictive biomarker for cisplatin-based chemotherapy.. Four distinct ERCC1 isoforms arising from alternative splicing have been described (201, 202, 203 and 204) but only the 202 isoform is functional in DNA excision repair, when interacting with its obligate partner XPF.”
Eur J Endocrinol |
Nov 29, 2017 | PubMed ID: 29187510 |
Read Article
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas.
Valeria Laufs, Barbara Altieri, …, Cristina L Ronchi
“Blocking of unspecific protein–antibody interactions was performed with 20% human AB serum in PBS for 1 h at room temperature.. Primary antibody for ERCC1 was the new highly specific monoclonal anti-mouse antibody (mAb) clone 4F9 (UM500008, dilution 1:100) that was purchased from OriGene Technologies (Rockville, MD, USA).. A mouse negative control was used (Dako North America).”
Arch Pathol Lab Med |
Sep 09, 2016 | PubMed ID: 27610644 |
Read Article
Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors.
Brittany N Bahamon, Feng Gao, Hadi Danaee
“nutes to 958C, for antigen retrieval. Slides were cooled to room temperature and incubated in a peroxidase blocking solution (Dako, Carpinteria, California) for 10 minutes. Slides were washed and incubated with the primary antibodies (ERCC1 and 4F9, OriGene, Rockville, Maryland; ERCC1 and D6G6, Cell Signaling Technology, Danvers, Massachusetts) for 1 hour at room temperature. Several iterations of antigen retrieval, primary antibody dilution, and incubation times were tested to determine the opti”.
Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody
David Hersi Smith, Anne-Marie Kanstrup Fiehn, …, Sussie Steen Jensen
“IHC inhibitionA peptide containing the antibody 4F9 epitope (AEYAISQ, sequence provided by Origene) (PolyPeptide Laboratories) was pre-incubated with antibody 4F9 at varying concentrations (overnight, 4°C). Slides were subsequently stained as previously described. “
BMC Biotechnol |
Nov 21, 2012 | PubMed ID: 23171216 |
Read Article
Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology
Donghui Ma, Dror Baruch, …, Wei-Wu He
” the cells completely. The 96 crude cell lysates were transferred to a 96-deep well plate with 2 ml capacity (Axygen) and spun at 4000 x rpm to remove insoluble cellular debris. The clarified supernatants were transferred to a 96-well v-shape plate (BD) and stored at -80C for future protein microarray printing. The recombinant protein expression for every overexpression lysate used for microarray printing was validated by Western-blot analysis with the anti-DDK antibody (OriGene, TA50011-100). “
Avaliações
Não há avaliações ainda.